THERAPEUTIC CLASS

Statin Treatment in Patients With Intracerebral Hemorrhage

---

Ever since the publication of the SPARCL trial (Stroke Prevention by Aggressive Reduction in Cholesterol Levels) in 2006, neurologists became aware of the fact that statins may increase the risk for future intracerebral hemorrhage
(ICH) in patients with previous ischemic stroke or ICH.1,2 At the same time, observational studies reported an
increased risk for hemorrhagic transformation or even symptomatic bleeding in ischemic stroke patients undergoing
thrombolysis who were pretreated with statins

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Cardiovascular & Hematopoietic System
Stator
Cholestor
Rosufer
Atorvastatin OGB

Specific Detail Info

Stroke. 2018;49:00-00

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment